Literature DB >> 1111924

The value of aspiration cytology in the diagnosis of breast cancer: experience at the Fondation Curie.

A Zajdela, N A Ghossein, J P Pilleron, A Ennuyer.   

Abstract

Aspiration cytology was performed on 2772 breast masses, all of which subsequently had open biopsies. Of the 1745 histologically malignant tumors, 1539 (88%) had a concordant cytologic diagnosis: 54 (0.3%) were diagnosed as probably malignant; 63 (3.6%) were false negatives; and 80 (0.5%) had inadequate smears for diagnosis. Of the histologically benign lesions, 916 (89%) had a concordant cytology: only 3 (0.3%) were false positives; cancer was suggested in 42 (0.4%); and the smears were inadequate in 66 cases (6.4%). Very small or very large sized cancer and a high degree of differentation were major causes of false negative aspirates. Recurrent tumors in those breasts exclusively treated by radiotherapy were documented by cytology in 56 of 69 cases (78%). Aspiration cytology is highly reliable when the diagnosis of cancer is made, but should be ignored if no malignant cells are observed.

Entities:  

Mesh:

Year:  1975        PMID: 1111924     DOI: 10.1002/1097-0142(197502)35:2<499::aid-cncr2820350231>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer.

Authors:  D Clarke; N Sudhakaran; C A Gateley
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Significance of Flow Cytometric DNA Analysis from Freshly Aspirated Samples.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

3.  Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.

Authors:  I O Ellis; S Humphreys; M Michell; S E Pinder; C A Wells; H D Zakhour
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 4.  Percutaneous biopsies of the breast: state of the art.

Authors:  B D Fornage
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jan-Feb       Impact factor: 2.740

5.  Monoclonal antibody B72.3 as a diagnostic adjunct in fine needle aspirates of breast masses.

Authors:  J Lundy; M Lozowski; Y Mishriki
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

6.  Immunocytochemistry with monoclonal antibody B72.3 applied to a spectrum of benign and malignant breast aspirates--strengths and pitfalls.

Authors:  J Lundy; M Lozowski; Y Mishriki
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

Review 7.  Percutaneous needle aspiration biopsy.

Authors:  M J McLoughlin; C S Ho; L C Tao
Journal:  Can Med Assoc J       Date:  1978-12-09       Impact factor: 8.262

8.  Diagnosis of breast lesions by aspiration biopsy cytology.

Authors:  T Kataoka; M Nishiki; T Matsuyama; M Yamane; N Kishi; K Dohi
Journal:  Jpn J Surg       Date:  1985-09

9.  Role of fine needle aspiration cytology in breast cancer screening.

Authors:  J Lamb; T J Anderson; M J Dixon; P A Levack
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

10.  Fine needle aspiration cytology of breast masses: an evaluation of its accuracy and reasons for diagnostic failure.

Authors:  J J Patel; P C Gartell; J A Smallwood; A Herbert; G Royle; R Buchanan; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1987-07       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.